Critical Reviews in Oral Biology & Medicine, Vol 10, 139-152, Copyright © 1999 by International & American Associations for Dental Research

ARTICLES

Apoptosis and predisposition to oral cancer

P. J. Polverini and J. E. Nor
Department of Oral Medicine/Pathology/Surgery, University of Michigan School of Dentistry, Ann Arbor 48109-1078, USA.

The term apoptosis, also known as programmed cell death (PCD), was coined by developmental biologists a number of years ago to describe a form of cell death characterized by several unique morphological and biochemical features. Genetic studies of the round worm Caeneorhabditis elegans, a simple multicellular organism, first revealed apoptosis to be an integral part of the developmental program. Subsequently, the importance of apoptosis in higher organisms was demonstrated in several eukaryotic systems. [n mammals, apoptosis is widespread during embryogenesis and in adult tissues. It is required for normal tissue homeostasis and for clonal selection in the immune system. In both developing and adult organisms, apoptosis plays a central role in reinforcing appropriate cellular patterns and in regulating cell number by eliminating cells that are harmful or no longer needed. It is becoming increasingly clear that disruption in the apoptosis pathway can contribute to the development of a number of developmental, inflammatory, degenerative, and neoplastic diseases. The effector arm of the apoptotic program includes members of the Bcl-2 gene family that function as either death agonists or death antagonists. These proteins participate in an elaborate genetically controlled biochemical pathway that functions to maintain tissue and organ homeostasis and serve as a critical defense mechanism to guard against malignant transformation. Cancer is the result of a series of genetic lesions that include activation of oncogenes and inactivation or loss of tumor suppressor genes. Several groups of investigators have observed that deregulated expression of oncogenes can subvert apoptotic pathways, resulting in prolonged cell survival. In pathological settings such as cancer, members of the Bcl-2 gene family are able to synergize with oncogenes and tumor suppressor genes to transform cells. In this review, we describe the process of apoptosis in mammalian cells and define the role and biochemical pathways through which the Bcl-2 gene family induce and/or protect cells from apoptosis. Last, we will discuss the evidence which suggests that alterations in this pathway may play a central role in tumorigenesis by allowing genetically damaged cells normally destined for elimination to persist, predisposing them to additional mutations and driving them to malignancy.

This article has been cited by other articles:

				G. M. Birdsey, N. H. Dryden, V. Amsellem, F. Gebhardt, K. Sahnan, D. O. Haskard, E. Dejana, J. C. Mason, and A. M. Randi Transcription factor Erg regulates angiogenesis and endothelial apoptosis through VE-cadherin Blood, April 1, 2008; 111(7): 3498 - 3506. [Abstract] [Full Text] [PDF]

				Y. Kim, S. Shintani, Y. Kohno, R. Zhang, and D. T. Wong Cyclin G2 Dysregulation in Human Oral Cancer Cancer Res., December 15, 2004; 64(24): 8980 - 8986. [Abstract] [Full Text] [PDF]

				W. C. Coffeen and T. J. Wolpert Purification and Characterization of Serine Proteases That Exhibit Caspase-Like Activity and Are Associated with Programmed Cell Death in Avena sativa PLANT CELL, April 1, 2004; 16(4): 857 - 873. [Abstract] [Full Text] [PDF]

				B. S. Chan, S. Endo, N. Kanai, and V. L. Schuster Identification of lactate as a driving force for prostanoid transport by prostaglandin transporter PGT Am J Physiol Renal Physiol, June 1, 2002; 282(6): F1097 - F1102. [Abstract] [Full Text] [PDF]

				S. Chen, A. Fribley, and C.-Y. Wang Potentiation of Tumor Necrosis Factor-mediated Apoptosis of Oral Squamous Cell Carcinoma Cells by Adenovirus-mediated Gene Transfer of NF-{kappa}B Inhibitor J. Dent. Res., February 1, 2002; 81(2): 98 - 102. [Abstract] [Full Text] [PDF]

				J. R. Starr, J. R. Daling, E. D. Fitzgibbons, M. M. Madeleine, R. Ashley, D. A. Galloway, and S. M. Schwartz Serologic Evidence of Herpes Simplex Virus 1 Infection and Oropharyngeal Cancer Risk Cancer Res., December 1, 2001; 61(23): 8459 - 8464. [Abstract] [Full Text] [PDF]